The global burden of IPF is expected to rise, due to the rapidly aging population of Asia Pacific region, with South Korea, in particular, having the highest incidence and prevalence rates of IPF.
Novotech 收购美国药物开发咨询公司 CBR International - 扩大药物开发和 FDA 监管专业领域
新加坡 – Novotech,亚太地区专业的生物技术 CRO ,今天宣布收购集提供药物产品开发、临床监查和战略监管于一体的咨询公司 CBR Internatio
阅读更多内容